Executive Interview | James Schutz, CEO of Oculus Innovative Sciences (OCLS)

Hi, this is Mike Elliott and you’re watching SECFilings-TV. In this episode we will be talking to Mr. James Schutz, CEO, President & Director of Oculus Innovative Sciences, ticker symbol OCLS. Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at